Internal Medicine, Pulmonary Disease · Williamsville, NY
NPI
1902889090
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
6460 Main St, Buffalo Cardiology & Pulmonary Assoc PC
Williamsville, NY, 14221
Phone (716) 634-5100
Groups this clinician bills Medicare through
Medicare paid, 2024
$40K
767 services
Medicare patients, 2024
231
Average age 72
Drug cost, 2024
$3.1M
4,255 prescriptions
Company payments, 2025
$28K
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James G Lampasso was code 99214 (office e&m - established), 265 times for 154 patients. In total James G Lampasso billed 767 services in 21 codes, and Medicare paid $40K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-02-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 265 | 154 | $87.81 | $23K |
| 94729 Pulmonary Function Testing | Office | 63 | 60 | $41.26 | $2,599 |
| 94727 Pulmonary Function Testing | Office | 62 | 59 | $32.45 | $2,012 |
| J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | Office | 59 | 56 | $0.15 | $8.83 |
| 94060 Pulmonary Function Testing | Office | 59 | 56 | $28.27 | $1,668 |
| 94729 Pulmonary Function Testing | Facility | 54 | 53 | $6.52 | $352 |
| 94727 Pulmonary Function Testing | Facility | 52 | 51 | $8.80 | $458 |
| 94060 Pulmonary Function Testing | Facility | 42 | 42 | $7.32 | $307 |
| 94010 Pulmonary Function Testing | Office | 20 | 19 | $18.44 | $369 |
| 99215 Office E&M - Established | Office | 18 | 16 | $129.23 | $2,326 |
| 94010 Pulmonary Function Testing | Facility | 16 | 15 | $6.12 | $97.88 |
By year: 2022 $66K for 917 services; 2023 $67K for 1,027 services; 2024 $40K for 767 services.
Medicare prescription drug claims, 2024
In 2024, the drug James G Lampasso prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 661 prescriptions and refills. In total James G Lampasso wrote 4,255 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 661 | 862 | 122 | $538K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 381 | 445 | 126 | $13K |
| Montelukast Sodium Generic | 353 | 670 | 74 | $3,919 |
| Prednisone Generic | 351 | 372 | 121 | $1,727 |
| Fluticasone Propionate Generic | 338 | 568 | 105 | $6,570 |
| Azelastine Hcl Generic | 231 | 373 | 75 | $5,856 |
| Nucala Mepolizumab | 179 | 181 | 21 | $691K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 149 | 187 | 37 | $37K |
| Symbicort Budesonide/Formoterol Fumarate | 134 | 208 | 34 | $46K |
| Methylprednisolone Generic | 129 | 129 | 101 | $829 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 128 | 148 | 26 | $20K |
| Breo Ellipta Fluticasone/Vilanterol | 119 | 125 | 18 | $49K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 113 | 149 | 29 | $92K |
| Azithromycin Generic | 109 | 130 | 45 | $904 |
| Ventolin Hfa Albuterol Sulfate | 64 | 70 | Under 11 | $4,382 |
Brand drugs: - claims; generic drugs: 2,193 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James G Lampasso $28K ($28K in general payments such as food, travel and fees) from 19 companies. The largest payer was GlaxoSmithKline, LLC. with $25K.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 65 | $25K |
| AstraZeneca Pharmaceuticals LP AZN | 15 | $662 |
| Merck Sharp & Dohme LLC MRK | 8 | $272 |
| Grifols USA, LLC | 9 | $204 |
| Actelion Pharmaceuticals US, Inc. JNJ | 9 | $202 |
| Electromed, Inc. ELMD | 7 | $190 |
| Viatris Specialty LLC | 8 | $147 |
| Regeneron Healthcare Solutions, Inc. REGN | 7 | $144 |
| Genzyme Corporation SNY | 3 | $135 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $128 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.